Cromatina / Epigenética
Los inhibidores de cromatina/epigenética son compuestos que modulan la estructura y función de la cromatina o interfieren con modificaciones epigenéticas, como la metilación del ADN y la modificación de histonas. Estos inhibidores son herramientas esenciales para estudiar la regulación de la expresión génica y el papel de la epigenética en enfermedades como el cáncer, los trastornos neurológicos y las anomalías del desarrollo. Al dirigirse a los procesos epigenéticos, estos inhibidores pueden alterar los patrones de expresión génica y ofrecer nuevas vías terapéuticas. En CymitQuimica, ofrecemos una amplia selección de inhibidores de cromatina/epigenética de alta calidad para apoyar su investigación en biología molecular, genética y epigenética.
Subcategorías de "Cromatina / Epigenética"
Se han encontrado 2235 productos de "Cromatina / Epigenética"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Vafidemstat
CAS:<p>Vafidemstat (ORY-2001) is a lysine-histone demethylase (LSD1)/MAO-B inhibitor for the study of neurological disorders.</p>Fórmula:C19H20N4O2Pureza:99.53%Forma y color:SolidPeso molecular:336.39CD235
CAS:<p>CD235 is a structurally similar analog of CD161. CD161 is an orally bioavailable inhibitor of BET bromodomain.</p>Fórmula:C26H20FN5O2Pureza:98%Forma y color:SolidPeso molecular:453.47GSK-3484862
CAS:<p>Gsk-3484862 is a non covalent inhibitor of DNA methyltransferase DNMT1 with anticancer activity.</p>Fórmula:C19H19N5OSPureza:99.87% - 99.963%Forma y color:SolidPeso molecular:365.45YM-08
CAS:<p>YM-08 (Compound 7a), a brain-penetrant SIRT2 inhibitor, exhibits an IC50 of 19.9 μM. Additionally, it acts as an inhibitor of Hsp70 [1].</p>Fórmula:C19H17N3OS2Pureza:98%Forma y color:SolidPeso molecular:367.49MAK683-CH2CH2COOH
CAS:<p>MAK683-CH2CH2COOH, an EED-targeting chemical, serves as a foundation for EED degrader-1 and PROTAC EED degrader-2 design.</p>Fórmula:C23H21FN6O3Pureza:98%Forma y color:SolidPeso molecular:448.45(1s,4s)-Menin-MLL inhibitor-23
<p>(1s,4s)-Menin-MLL Inhibitor-23, an enantiomer of Menin-MLL Inhibitor-23 (Example 99A), functions as an inhibitor of the menin-MLL interaction [1].</p>Fórmula:C36H53FN6O4Forma y color:SolidPeso molecular:652.84PHD2/HDACs-IN-1
CAS:<p>PHD2/HDACs-IN-1: strong PHD2/HDAC inhibitor (IC50: 1.15-26.60 μM), low-toxicity, protects kidneys from cisplatin-induced AKI.</p>Fórmula:C18H19N9O4Forma y color:SolidPeso molecular:425.4BRD-IN-3
CAS:<p>BRD-IN-3 is a highly potent PCAF bromodomain (BRD) inhibitor (IC50: 7 nM). It also exhibits activity against GCN5 and FALZ.</p>Fórmula:C21H25N5O3Pureza:98%Forma y color:SolidPeso molecular:395.45SMYD3-IN-1
CAS:<p>SMYD3-IN-1 is an irreversible and selective SMYD3 (SET and MYND domain containing 3) inhibitor(IC50 of 11.7 nM).</p>Fórmula:C28H31ClN4O3Pureza:98%Forma y color:SolidPeso molecular:507.02TCS HDAC6 20b
CAS:<p>TCS HDAC6 20b (HDAC6-IN-7) is an HDAC6 inhibitor that blocks the growth of breast cancer cells and can be used in cancer research.</p>Fórmula:C26H44N2O4SPureza:>99.99%Forma y color:SolidPeso molecular:480.7KDM4-IN-2
CAS:<p>KDM4-IN-2 is a potent and selective KDM4/KDM5 dual inhibitor with Kis of 4 and 7 nM for KDM4A and KDM5B, respectively.</p>Fórmula:C25H26N6OPureza:98%Forma y color:SolidPeso molecular:426.51MK-0626
CAS:<p>MK-0626 is an orally available dipeptidyl peptidase IV (DPP-4) inhibitor enhancing AMP, restoring the expression of GLP-1R. promoting neoangiogenesis.</p>Fórmula:C22H24F2N6O2Pureza:99.47% - >99.99%Forma y color:SolidPeso molecular:442.46Tankyrase-IN-5
CAS:<p>Tankyrase-IN-5 (Compound 30f), structurally related to MSC2504877, effectively inhibits tankyrase isoforms TNKS1 and TNKS2, with half-maximal inhibitory</p>Fórmula:C17H18N2O2Pureza:98%Forma y color:SolidPeso molecular:282.34PRMT5-IN-28
CAS:<p>PRMT5-IN-28 (compound 36) serves as an inhibitor of the protein arginine methyltransferase 5 (PRMT5) enzyme, which is implicated in various cellular processes</p>Fórmula:C18H19ClN4O5Pureza:98%Forma y color:SolidPeso molecular:406.82Brepocitinib
CAS:<p>Brepocitinib (PF-06700841) is a potent dual JAK1/TYK2 inhibitor (IC50s: 17 nM/23 nM). Brepocitinib also inhibits JAK2/3 (IC50s: 77 nM/6.49 μM).</p>Fórmula:C18H21F2N7OPureza:99.82%Forma y color:SolidPeso molecular:389.4JAK-IN-5
CAS:<p>JAK-IN-5 is a JAK inhibitor.</p>Fórmula:C27H31FN6OPureza:98.1% - 99.37%Forma y color:SolidPeso molecular:474.57PHD-IN-2
CAS:<p>PHD-IN-2 (Compound 91), a potent PHD antagonist with an IC50 of less than 5 nM, effectively stimulates erythropoietin synthesis in HEP3B cells with an EC50 of</p>Fórmula:C26H27N7O4Pureza:98%Forma y color:SolidPeso molecular:501.54PRMT5-IN-29
CAS:<p>PRMT5-IN-29 is a potent, orally active inhibitor of PRMT5, exhibiting an IC50 value of 1.5 μM, showing promise for use in advanced cancer research [1].</p>Fórmula:C18H20Cl3N5O5Pureza:98%Forma y color:SolidPeso molecular:492.74PRMT5-IN-25
CAS:<p>PRMT5-IN-25 (compound 503) is a potent inhibitor of PRMT5, exhibiting an inhibition constant (K i) of 0.06 nM and demonstrating antiproliferative properties [1</p>Fórmula:C24H21F3N6OPureza:98%Forma y color:SolidPeso molecular:466.46PARP7-IN-15
CAS:<p>PARP7-IN-15 (Compound 18) is a potent PARP7 inhibitor exhibiting an IC50 of 0.56 nM and demonstrates antitumor activity [1].</p>Fórmula:C23H24F6N6O4Pureza:98%Forma y color:SolidPeso molecular:562.46KDM5-C70
CAS:<p>KDM5-C70 is an ethyl ester derivative of KDM5-C49.</p>Fórmula:C17H28N4O3Pureza:97.63% - 99.86%Forma y color:SolidPeso molecular:336.43Pim-1 kinase inhibitor 5
CAS:<p>Pim-1 kinase inhibitor 5 (Compound 4c), with an IC50 of 0.61 μM, exhibits cytotoxicity against various cancer cell lines, including HepG2, MCF-7, PC3, and HCT-</p>Fórmula:C22H13Cl2N3OPureza:98%Forma y color:SolidPeso molecular:406.26Sirtuin-1 inhibitor 1
CAS:<p>Sirtuin-1 inhibitor 1 is an inhibitor against deacetylase-1 (Sirtuin-1) and can be used to study senescence and cell death in the organism.</p>Fórmula:C20H17N3O2Pureza:99.1%Forma y color:SolidPeso molecular:331.37BRD7-IN-1
CAS:<p>BRD7-IN-1, a BI7273 derivative, forms PROTAC VZ185, targeting BRD7/9 with DC50s of 4.5/1.8 nM via VHL ligand linkage.</p>Fórmula:C22H28Cl2N4O3Pureza:98.95%Forma y color:SolidPeso molecular:467.39Aurora Kinases-IN-4
CAS:<p>Aurora Kinases-IN-4 (Compound 11c) is a covalent, ATP-competitive inhibitor of aurora kinase A with an IC50 value of 1.7 nM.</p>Fórmula:C26H28N8OPureza:98%Forma y color:SolidPeso molecular:468.55Physachenolide C
CAS:<p>Physachenolide C, a selective BET inhibitor, induces apoptosis and arrests the cell cycle at the G0-G1 phase, exhibiting antitumor activity [1].</p>Fórmula:C30H40O9Pureza:98%Forma y color:SolidPeso molecular:544.63PHD2-IN-1
CAS:<p>PHD2-IN-1, a potent and orally active HIF prolyl hydroxylase 2 (PHD2) inhibitor, exhibits an IC50 of 22.53 nM and is applicable in anemia research [1].</p>Fórmula:C21H23ClN4O5Pureza:98%Forma y color:SolidPeso molecular:446.88BET-IN-16
CAS:<p>BET-IN-16 (Comp I), a bromodomain and extra-terminal (BET) inhibitor, demonstrates anticancer activity by impeding the growth of prostate cancer cells.</p>Fórmula:C31H25N5O3Pureza:98%Forma y color:SolidPeso molecular:515.56Antitumor agent-101
CAS:<p>Antitumor agent-101 is a selective, covalent inhibitor targeting lysine methyltransferases G9a/GLP, demonstrating IC50 values of 8.5 nM for G9a and 5.5 nM for</p>Fórmula:C26H38N6O3Pureza:98%Forma y color:SolidPeso molecular:482.62SJ1461
CAS:<p>SJ1461 is a potent, orally active inhibitor of the BET family, selectively targeting and inhibiting BRD2 (BD1), BRD2 (BD2), BRD4 (BD1), and BRD4 (BD2) with</p>Fórmula:C21H18ClN7OS2Pureza:98%Forma y color:SolidPeso molecular:484CBP-IN-1
CAS:<p>CBP-IN-1 (compound 12) acts as a potent CBP inhibitor exhibiting an IC50 of 1.5 nM and additionally suppresses CBP BRET and BRD4(1) with IC50 values of 690 nM</p>Fórmula:C27H33F2N7OPureza:98%Forma y color:SolidPeso molecular:509.59Eleven-Nineteen-Leukemia Protein IN-2
CAS:<p>Eleven-Nineteen-Leukemia Protein IN-2 (compound 23), an ENL inhibitor, exhibits an IC50 of 10.7 nM and is utilized for leukemia research [1].</p>Fórmula:C22H23N5O2Pureza:98%Forma y color:SolidPeso molecular:389.45LSD1-UM-109
CAS:<p>LSD1-UM-109 is a highly potent and reversible inhibitor of LSD1, demonstrating an IC50 of 3.1 nM.</p>Fórmula:C29H27FN6Pureza:98%Forma y color:SolidPeso molecular:478.56Bromodomain inhibitor-12
CAS:<p>Bromodomain Inhibitor-12 (example 303) is a research compound utilized in the study of autoimmune and inflammatory diseases [1].</p>Fórmula:C28H38N4O5Pureza:98%Forma y color:SolidPeso molecular:510.63MAT2A-IN-10
CAS:<p>MAT2A-IN-10 (Compound 28), an orally active inhibitor of MAT2A, exhibits an IC50 of 26 nM and is utilized in cancer research [1].</p>Fórmula:C27H24F2N6O4Pureza:98%Forma y color:SolidPeso molecular:534.51PIM1-IN-4
CAS:<p>PIM1-IN-4: strong PIM1 inhibitor, also blocks SGK-1, PKA, CaMK-1, GSK3β, MSK1; promising for cancer studies.</p>Fórmula:C27H25BrCl2CuN6OPureza:98%Forma y color:SolidPeso molecular:663.88Eleven-Nineteen-Leukemia Protein IN-3
CAS:<p>ENL YEATS inhibitor Eleven-Nineteen-Leukemia Protein IN-3, IC50 15.4 nM, orally active, suppresses MYC, stabilizes ENL in vitro.</p>Fórmula:C28H27N5O2Pureza:98%Forma y color:SolidPeso molecular:465.55MAT2A-IN-12
CAS:<p>MAT2A Allosteric Inhibitor 2 is a potent, selective inhibitor exhibiting an IC50 of 5 nM and demonstrates nanomolar efficacy (IC50 = 5 μM) in proliferation</p>Fórmula:C20H17NO3Pureza:98%Forma y color:SolidPeso molecular:319.35CBP/p300-IN-21
CAS:<p>CBP/p300-IN-21 (Compound 5d), a selective inhibitor of CBP/p300 with IC50 values of 0.07 μM for p300 and 1.755 μM for CBP, reduces H3K18Ac levels and inhibits</p>Fórmula:C19H16ClNO4Pureza:98%Forma y color:SolidPeso molecular:357.79BRD4 Inhibitor-28
CAS:<p>BRD4 Inhibitor-28 (Compound 18), an orally active molecule, selectively inhibits the bromodomains of BRD4 (BRD4-BD1 and BRD4-BD2) with IC50 values of 15 and 55</p>Fórmula:C23H21N3O3Pureza:98%Forma y color:SolidPeso molecular:387.43Bromodomain inhibitor-12 (edisylate)
CAS:<p>Bromodomain Inhibitor-12 Edisylate (example 303) serves as a bromodomain inhibitor applicable to autoimmune and inflammatory disease research [1].</p>Fórmula:C30H44N4O11S2Pureza:98%Forma y color:SolidPeso molecular:700.82HIF-2α-IN-9
CAS:<p>HIF-2α-IN-9 (compound 35r) serves as an HIF-2α inhibitor, effectively suppressing VEGF-A with an IC50 of 305 nM, and modulating growth-promoting genes within</p>Fórmula:C12H13F5O4S2Pureza:98%Forma y color:SolidPeso molecular:380.35(S,R)-CFT8634
CAS:<p>(S,R)-CFT8634 is a selective and orally active BRD9 protein degrader with potential for researching BRD9-mediated disorders, such as abnormal cellular</p>Fórmula:C37H45F3N6O5Pureza:98%Forma y color:SolidPeso molecular:710.79FM-479
CAS:<p>FM-479, a structural analog of FM-381, lacks inhibition of JAK3/kinases within 100-300 nM, serving as FM-381's negative control.</p>Fórmula:C25H26N6O2Pureza:98%Forma y color:SolidPeso molecular:442.523WM-586
CAS:<p>WM-586 is a covalent inhibitor of WDR5 that impedes the WDR5-MYC binding.</p>Fórmula:C20H20F3N5O3SPureza:98%Forma y color:SolidPeso molecular:467.47JG-2016
CAS:<p>JG-2016, as a histone acetyltransferase 1 inhibitor, inhibits growth of human cancer cell lines and inhibits enzymatic activity in cellulose.</p>Fórmula:C18H21ClN4O3Pureza:99.00% - 99.37%Forma y color:SolidPeso molecular:376.84GSK217
CAS:<p>GSK217 is a potent and selective inhibitor of the bromo and extraterminal domain (BET) second bromodomain (BD2) with high solubility, utilized in oncology and</p>Fórmula:C20H20N6OPureza:98%Forma y color:SolidPeso molecular:360.41AGI-25696
CAS:<p>AGI-25696 inhibits MATA2, blocking MTAP-deleted tumor growth, potential for cancer research.</p>Fórmula:C27H18N4OPureza:98.40% - 99.74%Forma y color:SolidPeso molecular:414.46JAK-IN-31
CAS:<p>JAK-IN-31 (Example 75), a JAK inhibitor, demonstrates IC50 values of ≤0.01 µM for JAK1, ≤0.01 µM for JAK2, 0.01-0.1 µM for JAK3, and ≤0.01 µM for Tyk2,</p>Fórmula:C21H19N7O2S2Pureza:98%Forma y color:SolidPeso molecular:465.55ABBV-712
CAS:<p>ABBV-712 is a selective Tyrosine Kinase 2 (TYK2) inhibitor, demonstrating an IC50 value of 0.195 μM, and is implicated in the regulation of autoimmune diseases</p>Fórmula:C24H28N4O5Pureza:98%Forma y color:SolidPeso molecular:452.5GSK737
CAS:<p>GSK737 is a dual inhibitor of BRD4 BD1 and BD2, exhibiting pIC50 values of 5.3 and 7.3, respectively.</p>Fórmula:C20H21N5O2Pureza:98%Forma y color:SolidPeso molecular:363.41AAPK-25
CAS:<p>AAPK-25, a dual Aurora/PLK inhibitor, disrupts mitosis, induces apoptosis, and has antitumor properties.</p>Fórmula:C21H13Cl2N3O2SPureza:97.05%Forma y color:SolidPeso molecular:442.32Demethyleneberberine chloride
CAS:<p>Demethyleneberberine chloride, a natural mitochondria-targeted antioxidant, mitigates colitis in mice and suppresses inflammatory responses by blocking the NF-</p>Fórmula:C19H18ClNO4Pureza:98%Forma y color:SolidPeso molecular:359.8Amelparib
CAS:<p>Amelparib (JPI-289) is an inhibitor of the poly-ADP-ribose polymerase.</p>Fórmula:C19H25N3O3Pureza:98%Forma y color:SolidPeso molecular:343.42BATCP
CAS:<p>BATCP is an inhibitor of histone deacetylases (HDAC) [1].</p>Fórmula:C23H28F3N3O6Forma y color:SolidPeso molecular:499.487AKB-6899
CAS:<p>AKB-6899 is an inhibitor of prolyl hydroxylase domain 3 (PHD3) and increases the soluble form of the VEGF receptor (sVEGFR-1) production from GM-CSF-treated</p>Fórmula:C14H11FN2O4Pureza:97.87%Forma y color:SolidPeso molecular:290.25Sirt2-IN-5
CAS:<p>Sirt2-IN-5 is a potent inhibitor of SIRT2.</p>Fórmula:C26H27Cl2N5O3Forma y color:SolidPeso molecular:528.43MARK-IN-1
CAS:<p>MARK-IN-1 is a potent microtubule affinity regulating kinase (MARK) inhibitor, (IC50<0.25 nM).</p>Fórmula:C22H23F2N7OSPureza:98%Forma y color:SolidPeso molecular:471.53XDM-CBP
CAS:<p>XDM-CBP is an effective and selective CBP/p300 bromodomain inhibitor.</p>Fórmula:C21H22N2O4Pureza:98%Forma y color:SolidPeso molecular:366.41DY-46-2
CAS:<p>DY-46-2 is a DNMT3A inhibitor (IC50: 0.39 ± 0.23 μM) with anticancer activity and is used in cancer and tumor research.</p>Fórmula:C19H22N6O5SPureza:99.12% - 99.12%Forma y color:SolidPeso molecular:446.48Prolyl Hydroxylase inhibitor 1
CAS:<p>Prolyl Hydroxylase inhibitor 1 is an orally active inhibitor of hypoxia inducible factor (HIF)-prolyl hydroxylase (PHD) (IC50 of 62.23 nM).</p>Fórmula:C19H18ClN5O4Pureza:98%Forma y color:SolidPeso molecular:415.83K-756
CAS:<p>K-756 is a direct and selective inhibitor of tankyrase (TNKS), which inhibits the ADP-ribosylation activity of TNKS1 (IC50 = 31 nM) and TNKS2 (IC50 = 36 nM).</p>Fórmula:C24H27N5O3Pureza:99.81%Forma y color:SolidPeso molecular:433.5QL-1200186
CAS:<p>QL-1200186 is an orally active, selective TYK2 inhibitor that, upon dose-dependent oral administration, suppresses interferon-γ (IFNγ) production following</p>Fórmula:C26H27N7O3Pureza:98%Forma y color:SolidPeso molecular:485.54JAK kinase-IN-1
CAS:<p>JAK kinase-IN-1 (Example 1) functions as a potent inhibitor targeting the JAK family, which includes TYK2, JAK1, JAK2, and JAK3, with IC50 values of 4.2 nM, 32</p>Fórmula:C17H19F2N7OSPureza:98%Forma y color:SolidPeso molecular:407.44JAK-IN-25
CAS:<p>JAK-IN-25 (compound 19), a potent JAK inhibitor, exhibits IC50 values of 6 nM for TYK2, 21 nM for JAK1, 8 nM for JAK2, and 1051 nM for JAK3.</p>Fórmula:C19H17N5O4Pureza:98%Forma y color:SolidPeso molecular:379.37JAK-IN-17
<p>"JAK-IN-17: Potent JAK inhibitor for studying ocular, skin, and respiratory diseases."</p>Fórmula:C33H38F2N6O8Forma y color:SolidPeso molecular:684.69GSK-A
CAS:<p>GSK-A is a Histone Lysine Methyltransferase EZH2 inhibitor.</p>Fórmula:C21H25N5O2Forma y color:SolidPeso molecular:379.46BChE/HDAC6-IN-1
CAS:<p>BChE/HDAC6-IN-1 is a dual BChE/HDAC6 inhibitor that exhibits potent and selective inhibition with IC50 values of 4 nM for BChE and 8.9 nM for HDAC6.</p>Fórmula:C34H43N5O5Pureza:98%Forma y color:SolidPeso molecular:601.74KDM2B-IN-1
CAS:<p>KDM2B-IN-1: Potent, specific KDM2B histone demethylase inhibitor for hyperproliferative disease research.</p>Fórmula:C21H30N4O2SForma y color:SolidPeso molecular:402.56HDAC/HSP90-IN-3
CAS:<p>HDAC/HSP90-IN-3, a dual inhibitor targeting fungal Hsp90 (IC50: 0.83 μM) & HDAC (IC50: 0.91 μM), counters azole-resistant C. albicans.</p>Fórmula:C26H33N5O6Forma y color:SolidPeso molecular:511.57RK-701
CAS:<p>RK-701: G9a inhibitor, IC50 23-27 nM, increases HbF/γ-Globin/BGLT3, decreases H3K9me2, inhibits BCL11A/ZBTB7A.</p>Fórmula:C26H30N4O3Forma y color:SolidPeso molecular:446.54Aurora kinase inhibitor-8
CAS:<p>Aurora kinase inhibitor-8 is a highly selective inhibitor of Aurora kinase.</p>Fórmula:C30H29N7O3Forma y color:SolidPeso molecular:535.6EPZ-030456
CAS:<p>EPZ-030456 is an effective and selective inhibitor of the SMYD3.</p>Fórmula:C28H34ClN5O4SForma y color:SolidPeso molecular:572.12PF-06679142
CAS:<p>PF-06679142 is an effective AMPK activator. PF-06679142 exhibited robust activation of AMPK in rat kidneys as well as desirable oral absorption.</p>Fórmula:C20H17F2NO3Pureza:98%Forma y color:SolidPeso molecular:357.35CC-90005
CAS:<p>CC-90005 is a potent, selective oral PKC-θ inhibitor with an IC50 of 8 nM, preferential over PKC-δ, and inhibits T cell activation.</p>Fórmula:C21H27F2N7O2Forma y color:SolidPeso molecular:447.48PRMT5-IN-16
CAS:<p>PRMT5-IN-16 (Compound 20) is an antitumor PRMT5 inhibitor linked to epigenetic changes.</p>Fórmula:C25H34N8O2Forma y color:SolidPeso molecular:478.59Tyk2-IN-9
CAS:<p>Tyk2-IN-9: selective Tyk-2 inhibitor, IC50 of 0.076 nM (TYK2-JH2), 1.8 nM (JAK1-JH2), for inflammation/autoimmune research.</p>Fórmula:C20H17N9Pureza:98%Forma y color:SolidPeso molecular:383.41OM-1700
CAS:<p>OM-1700 inhibits tankyrase 1 (IC50=127 nM) and 2 (IC50=14 nM); hinders colon cancer cell growth, COLO 320DM (GI50=650 nM).</p>Fórmula:C25H23FN6O2Forma y color:SolidPeso molecular:458.49FD1024
CAS:<p>FD1024 is a potent PIM inhibitor, displaying inhibitory concentrations (IC50s) of 1.96 nM, 38.9 nM, and 4.17 nM for PIM1, PIM2, and PIM3, respectively.</p>Fórmula:C21H20F2N4O2SPureza:98%Forma y color:SolidPeso molecular:430.47NMS-P515
CAS:<p>NMS-P515 is an effective, orally active, and stereospecific PARP-1 inhibitor (Kd: 16 nM and an IC50: 27 nM (in Hela cells)). It has anti-tumor activity.</p>Fórmula:C21H29N3O2Pureza:98%Forma y color:SolidPeso molecular:355.47CARM1-IN-3
CAS:<p>CARM1-IN-3 (compound 17b) is a potent, selective inhibitor of co-activator associated arginine methyltransferase (CARM1), exhibiting IC50 values of 0.07 µM for</p>Fórmula:C24H32N4O2Pureza:98%Forma y color:SolidPeso molecular:408.54RK-0133114
<p>RK-0133114, R-enantiomer of RK-701, is a G9a inhibitor (IC50 = 3.7 μM) for SCD research.</p>Fórmula:C26H30N4O3Forma y color:SolidPeso molecular:446.54JQKD82 dihydrochloride
CAS:<p>JQKD82 (JADA82) dihydrochloride, a cell-permeable and selective inhibitor of KDM5, enhances H3K4me3 levels, making it effective for multiple myeloma research [1].</p>Fórmula:C27H42Cl2N4O5Forma y color:SolidPeso molecular:573.55QQN-00358
CAS:<p>QQN-00358 is a novel potent and selective tankyrase (TNKS) inhibitor.</p>Fórmula:C26H24F3N3O4Forma y color:SolidPeso molecular:499.48PARP1-IN-7
CAS:<p>PARP1-IN-7 functions as an anticancer agent by inhibiting poly(ADP-ribose) polymerase-1 (PARP1).</p>Fórmula:C24H23N5OForma y color:SolidPeso molecular:397.47MS31
CAS:<p>MS31 is a potent and highly affinity inhibitor of spindlin 1 (SPIN1).</p>Fórmula:C20H27N3O2Pureza:98%Forma y color:SolidPeso molecular:341.45Upadacitinib tartrate
CAS:<p>Upadacitinib: potent, selective JAK1 inhibitor, 74x preferential to JAK2, effective in rat arthritis.</p>Fórmula:C21H33F3N6O11Pureza:98%Forma y color:SolidPeso molecular:602.521CBP/p300-IN-15
CAS:<p>CBP/p300-IN-15 inhibits p300 (IC50: 2.5 nM) & CBP (28 nM), affects OVCAR-3 (EC50: 0.865 μM) & A2780 cells (2.71 μM) for ovarian cancer research.</p>Fórmula:C26H28N4O5Forma y color:SolidPeso molecular:476.52Ro 32-0432 hydrochloride
CAS:<p>Ro 32-0432 is a selective, ATP-competitive, oral pan-PKC inhibitor exhibiting inhibitory effects on PKCα, PKCβI, PKCβII, PKCγ, and PKCε.</p>Fórmula:C28H28N4O2Pureza:98%Forma y color:SolidPeso molecular:452.55BET-IN-9
CAS:<p>BET-IN-9 is a BET inhibitor[1].</p>Fórmula:C22H24N4O3Forma y color:SolidPeso molecular:392.45PIM-IN-2
CAS:<p>PIM-IN-2 (Pim-2) is a potent inhibitor of Pim kinases, demonstrating an inhibition concentration half-maximal (IC50) value of 25 nM .</p>Fórmula:C19H22N4O2Pureza:98%Forma y color:SolidPeso molecular:338.4SP-2-225
CAS:<p>SP-2-225, a selective inhibitor of HDAC6, augments the production of cancer-associated antigens and enhances macrophage antigen cross-presentation to T cells,</p>Fórmula:C28H34N2O3Pureza:98%Forma y color:SolidPeso molecular:446.58MARK-IN-2
CAS:<p>MARK-IN-2 is a potent microtubule affinity regulating kinase (MARK) inhibitor,(IC50:5 nM).</p>Fórmula:C18H18ClF2N5OSPureza:98%Forma y color:SolidPeso molecular:425.88PIN1 inhibitor 2
CAS:<p>PIN1 inhibitor 2, compound 12, impedes PIN1, shows promise in breast cancer study, and has IC50 of 9.55 μM in MCF7 cells.</p>Fórmula:C16H21N3S2Forma y color:SolidPeso molecular:319.49CBB1007
CAS:<p>CBB1007 is a potent, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1).</p>Fórmula:C27H34N8O4Pureza:98%Forma y color:SolidPeso molecular:534.61AMPK activator 7
CAS:<p>AMPK activator 7 (I-3-24, EC50: 8.8 nM) targets AMPK-related disorders like type 2 diabetes and obesity.</p>Fórmula:C23H22F3N3O5Forma y color:SolidPeso molecular:477.43PARP7-probe-1
CAS:<p>PARP7-probe-1: biotinylated, chemiluminescent PARP7 active site probe for research use.</p>Fórmula:C36H49F3N8O5SForma y color:SolidPeso molecular:762.89PRT543
CAS:<p>PRT543 is a potent selective inhibitor of the protein arginine methyltransferase 5 (PRMT5), showing a wide range of antitumor activities in vitro and in vivo. The compound also showed an inhibitory effect on methyltransferase activity of the PRMT5/MEP50 complex with an IC50 value of 10.8 nM.</p>Fórmula:C17H17ClN4O4Forma y color:SolidPeso molecular:376.79JAK-IN-24
CAS:<p>JAK-IN-24: JAK inhibitor, IC50: 0.534 nM (4 μM ATP), 24 nM (1mM ATP), STAT5 phosphorylation IC50: 86.171 nM.</p>Fórmula:C20H25N5O2Forma y color:SolidPeso molecular:367.44EZH2-IN-14
CAS:<p>EZH2-IN-14 selectively inhibits EZH2 at 12 nM IC50, has >200-fold specificity over EZH1, reducing H3K27me3 levels.</p>Fórmula:C31H39N7O2Forma y color:SolidPeso molecular:541.69
